# Documentation Structure

  - üìÅ **assets/**
    - üìÅ **diagrams/**
      - [platform-diagram](assets/diagrams/platform-diagram.html)
  - üìÅ **benefits/**
    - [Cost Savings from Decentralized Clinical Trials](benefits/cost-savings-from-decentralized-clinical-trials.md)
    - [20X the Speed of Curing Diseases](benefits/faster-progress.md)
    - [Improving Treatment Affordability and Accessibility](benefits/improving-treatment-affordability-and-accessibility.md)
    - [Lower Costs of Validated Observational Research for Efficacy](benefits/lower-costs-of-validated-observational-research-for-efficacy.md)
    - [95% Lower Costs of Clinical Trials and Treatments](benefits/lower-costs.md)
    - [Lower Drug Prices](benefits/lower-drug-prices.md)
    - [Economic Incentives for Medical Cures vs Symptom Management](benefits/more-cures-and-less-lifelong-attempts-at-masking-symptoms.md)
    - [Overall Economic Benefits](benefits/overall-economic-benefits.md)
    - [100% Patient Participation in Trials](benefits/patient-participation.md)
    - [17 years to 2 Year From Research to Treatment](benefits/time-to-treatment.md)
  - üìÅ **blueprint/**
    - [Incentivized Actions for Global Blueprint Adoption](blueprint/blueprint-gas.md)
    - [Framework for a World Without Disease](blueprint/blueprint-high-level.md)
    - [Blueprint for a World Without Disease](blueprint/blueprint-sitemap.md)
    - [Strategy for a World Without Disease](blueprint/blueprint-strategy.md)
    - [Creating a World Without Disease](blueprint/blueprint-summary.md)
    - [Creating a World Without Disease](blueprint/blueprint.md)
  - üìÅ **clinical-trials/**
    - üìÅ **decentralized-methods/**
      - [DeSci DAO AI Agent Framework](clinical-trials/decentralized-methods/desci-ai-dao.md)
    - üìÅ **methodologies/**
      - [üìñKey Definitions](clinical-trials/methodologies/definitions.md)
    - üìÅ **protocols/**
      - [Experimental Protocol for Crowdsourcing Longevity Research](clinical-trials/protocols/crowdsourcing-longevity-research.md)
  - üìÅ **community/**
    - üìÅ **community_volunteers/**
      - [Community Volunteers Directory](community/community_volunteers/README.md)
    - üìÅ **daos/**
      - [vita-dao](community/daos/vita-dao.html)
    - üìÅ **developers/**
      - [Developers Directory](community/developers/README.md)
    - üìÅ **funding_sources/**
      - [Funding Sources Directory](community/funding_sources/README.md)
    - üìÅ **governance/**
      - [dFDA Collaboration Framework](community/governance/dfda-collaboration-framework.md)
    - üìÅ **healthcare_providers/**
      - [Healthcare Providers Directory](community/healthcare_providers/README.md)
    - üìÅ **industry_stakeholders/**
      - [Industry Stakeholders Directory](community/industry_stakeholders/README.md)
    - üìÅ **open-source-projects/**
      - [Open Source Projects for Clinical Discovery](community/open-source-projects/open-source-projects.md)
    - üìÅ **partners/**
      - [ageless-partners](community/partners/ageless-partners.md)
      - [Partners Directory](community/partners/README.md)
    - üìÅ **patient_advocacy/**
      - [Crowdsourcing Cures](community/patient_advocacy/crowdsourcing-cures.md)
      - [Patient Advocacy Directory](community/patient_advocacy/README.md)
    - üìÅ **projects/**
      - [projects Directory](community/projects/README.md)
    - üìÅ **regulatory_legal/**
      - [Regulatory and Legal Partners Directory](community/regulatory_legal/README.md)
    - üìÅ **researchers/**
      - [Researchers Directory](community/researchers/README.md)
    - üìÅ **resources/**
      - [Resources Directory for dFDA](community/resources/README.md)
    - üìÅ **templates/**
      - [Open-Source Project Overview](community/templates/open_source_project.md)
      - [Partner Introduction Template](community/templates/partner_introduction.md)
      - [project Proposal Template](community/templates/project_proposal.md)
    - [Contributing to the Community Directory](community/CONTRIBUTING.md)
    - [digital-health-ecosystem](community/digital-health-ecosystem.html)
    - [open-source](community/open-source.html)
    - [OpenCures](community/opencures.md)
    - [Community Directory](community/README.md)
    - [Weavechain](community/weavechain.md)
  - üìÅ **conditions/**
    - [long-covid](conditions/long-covid.html)
    - [Scabies](conditions/scabies.md)
  - üìÅ **data-standards/**
    - [data-types-and-quantities](data-standards/data-types-and-quantities.html)
  - üìÅ **disease-eradication-act/**
    - [Quantitative Cost-Benefit Analysis of the Disease Eradication Act](disease-eradication-act/disease-eradication-act-cost-benefit-analysis.md)
    - [Disease Eradication Act](disease-eradication-act/disease-eradication-act-details.md)
    - [Disease Eradication Act: Executive Summary](disease-eradication-act/disease-eradication-act-summary.md)
    - [Disease Eradication Act](disease-eradication-act/disease-eradication-act.md)
  - üìÅ **economic-models/**
    - [Economic Impact of Prescription-Only Classification for Safe Drugs](economic-models/benfits-of-over-the-counter-classification.md)
    - [Rx-to-OTC Switch Impact on Drug Prices and Access](economic-models/cost-benefit-analysis-for-drug-classification.md)
    - [dFDA Cost Benefit Analysis and Return on Inveestment](economic-models/dfda-cost-benefit-analysis.md)
    - [NIH Grant Process Efficiency Analysis](economic-models/nih-grant-efficiency-analysis.md)
    - [Quantifying the Value of Medical Treatments to Humanity](economic-models/quantitative-value-medical-treatment.md)
  - üìÅ **features/**
    - üìÅ **analytics/**
      - üìÅ **models/**
        - [analytical-model-and-property-descriptions](features/analytics/models/analytical-model-and-property-descriptions.html)
      - [Causal Inference Analysis](features/analytics/causal-inference-analysis.md)
    - üìÅ **browser-extension/**
      - [Browser Extension for Tracking Outcomes](features/browser-extension/browser-extension.md)
    - üìÅ **clinipedia/**
      - [Clinipedia: The Wikipedia of Clinical Research](features/clinipedia/clinipedia.md)
    - üìÅ **fdai/**
      - [Quantitative Data for Drug Regulation](features/fdai/drug-classification.md)
      - [The FDA Innovation through Data and AI Act (FDAi Act)](features/fdai/fdai-act.md)
      - [Autonomous FDAi Agent for Health Optimization](features/fdai/fdai-system-prompt.md)
      - [Automating Clinical Research: Cost Savings and Data Collection](features/fdai/fdai.md)
      - [Petition for the Establishment of the FDAi System](features/fdai/petition.md)
      - [The Case for Personal FDAi Agents](features/fdai/presentation.md)
      - [Inflammation-Mediated Depression and Dietary Adjustments](features/fdai/scenario.md)
      - [FDAi Agent Analyzes Patient's Health Concerns](features/fdai/simulated-conversation.md)
    - [Causal Inference and Optimal Daily Value Determination](features/data-analysis.md)
    - [üì≤ Data Collection Plugins](features/data-collection-plugins.md)
    - [Data Collection Methods and Types](features/data-collection.md)
    - [Data Import Framework](features/data-import.md)
    - [FDAi Gateway API Nodes](features/data-silo-api-gateways.md)
    - [Decision Support Notifications](features/decision-support-notifications.md)
    - [DeSci Exchange](features/desci-exchange.md)
    - [üë®‚Äçü§ù‚Äçüë® The Digital Twin Safe üîí](features/digital-twin-safe.md)
    - [Digital Twin Skeleton Key NFT](features/digital-twin-skeleton-key-nft.md)
    - [Global Health Unifier Agent](features/global-health-unifier-agent.md)
    - [Human File System](features/human-file-system-protocol.md)
    - [Life Force Score](features/life-force-score-nft.md)
    - [No-Code Health App Builder](features/no-code-app-builder.md)
    - [Notifications with Action Buttons](features/notifications.md)
    - [Observational Studies Plugin](features/observational-studies.md)
    - [Optimitron AI Agent](features/optomitron-ai-agent.md)
    - [optomitron-real-time-notifications-plugin](features/optomitron-real-time-notifications-plugin.html)
    - [üè∑ Outcome Labels Plugin](features/outcome-labels-plugin.md)
    - [Outcome Labels](features/outcome-labels.md)
    - [PersonalFDA Nodes](features/personal-fda-nodes.md)
    - [Predictor Search Engine Plugin](features/predictor-search-engine.md)
    - [ü•ï Root Cause Analysis Plugin](features/root-cause-analysis-plugin.md)
    - [Root Cause Analysis Reports](features/root-cause-analysis-reports.md)
    - [Study Review Agent](features/study-review-agent.md)
  - üìÅ **interventions/**
    - [Cerebrolysin](interventions/cerebrolysin.md)
    - [faah-out-mutation](interventions/faah-out-mutation.html)
    - [Focused Ultrasound](interventions/focused-ultrasound.md)
    - [ketamine](interventions/ketamine.html)
    - [Memantine](interventions/memantine.md)
  - üìÅ **problems/**
    - üìÅ **statistics/**
      - [Clinical Trials Cost $41,413 Per Trial Participant](problems/statistics/cost-per-participant.md)
      - [$1.6 Billion Per New Treatment Falls on Patients](problems/statistics/cost-per-treatment.md)
      - [120,000 US Deaths Per Decade Due to Drug Lag](problems/statistics/deaths-due-to-drug-lag.md)
      - [85% of Willing Participants Excluded from Trials](problems/statistics/percent-excluded-from-trials.md)
      - [95% of Diseases Have NO FDA-Approved Treatments](problems/statistics/percent-of-diseases-with-fda-approved-treatments.md)
      - [166 billion potential treatments have not been tested](problems/statistics/treatments-tested.md)
      - [2 Billion People With Uncured Diseases](problems/statistics/uncured-people.md)
      - [44 Years Since Last Cure](problems/statistics/years-since-last-cure.md)
    - [üßÆ Bias Against Approving Effective Treatments](problems/bias-against-approval.md)
    - [Clinical Research is Expensive](problems/clinical-research-is-expensive.md)
    - [Clinical Research is Slow](problems/clinical-research-is-slow.md)
    - [üí∞ Clinical Research is Too Expensive](problems/clinical-research-is-too-expensive.md)
    - [üé≠ Conflicts of Interest Industry-Controlled Research](problems/conflicts-of-interest.md)
    - [Deaths Due to US Regulatory Drug Lag](problems/deaths-due-to-us-regulatory-drug-lag.md)
    - [90% of Willing Patients Do Not Participate in Clinical Trials](problems/difficulty-participating.md)
    - [‚è± Deaths Due to US Regulatory "Drug Lag"](problems/drug-lag.md)
    - [Lack of Logical Reasoning Based on Quantitative Cost-Benefit Analysis in FDA Decisions](problems/fda-decisions-not-based-on-cost-benefit-analysis.md)
    - [ü§í Insufficient ROI to Discover Treatments for Rare Diseases](problems/insufficient-roi-to-discover-treatments-for-rare-diseases.md)
    - [üé© Excessive Patent Monopolies](problems/monopolies.md)
    - [Negative Results are Never Published](problems/negative-results-are-never-published.md)
    - [No Treatment Effectiveness Rankings](problems/no-comparative-effectiveness-rankings.md)
    - [No Data on Unpatentable Treatments](problems/no-data-on-unpatentable-molecules.md)
    - [üìÉ No Incentive to Discover Benefits of Off-Patent Treatments](problems/no-incentive-to-discover-benefits-of-off-patent-treatments.md)
    - [No Long-Term Outcome Data](problems/no-long-term-outcome-data.md)
    - [People With Rare Disease are Severely Punished](problems/people-with-rare-disease-are-severely-punished.md)
    - [Pre-Determining Clinical Endpoints Requires Psychic Powers](problems/pre-determining-clinical-endpoints-requires-psychic-powers.md)
    - [Problems in Clinical Research](problems/problems-in-clinical-research.md)
    - [‚ò† Slowed Growth in Life Expectancy](problems/slowed-growth-in-life-expectancy.md)
    - [Trials Often Aren't Representative of Real Patients](problems/trials-often-arent-representative-of-real-patients.md)
    - [No Data on Unpatentable Molecules](problems/unpatentable-treatments.md)
    - [Trials Often Aren't Representative of Real Patients](problems/unrepresentative-participants.md)
    - [We Know Next to Nothing](problems/we-know-nothing.md)
    - [‚ùì We Only Know The Effects of 0.000000002% of Potential Therapies](problems/we-only-know-the-effects-of-0000000002-of-potential-therapies.md)
  - üìÅ **proposals/**
    - [üí° The Decentralized FDA](proposals/dfda-act.md)
    - [50/50 Health Savings Sharing Program](proposals/health-savings-sharing.md)
    - [use-github-for-task-management](proposals/use-github-for-task-management.md)
  - üìÅ **reference/**
    - üìÅ **cost-barriers/**
      - üìÅ **executive-summary/**
        - [Clinical Trial Decision-making Model](reference/cost-barriers/executive-summary/e1-clinical-trial-decision-making-model.md)
        - [Clinical Trial Cost Analysis by Therapeutic Area and Phase](reference/cost-barriers/executive-summary/e2-analysis-of-costs.md)
        - [Barriers to Clinical Trials in the United States](reference/cost-barriers/executive-summary/e3-barriers-to-clinical-trials.md)
        - [High Financial Costs in Drug Development](reference/cost-barriers/executive-summary/e31-high-financial-cost.md)
        - [Lengthy Timelines in Clinical Trials](reference/cost-barriers/executive-summary/e32-lengthy-timelines.md)
        - [Difficulties in Recruiting and Retaining Clinical Trial Participants](reference/cost-barriers/executive-summary/e33-difficulties-in-recruiting-and-retaining-participants.md)
        - [Increasing Competition for Qualified Investigators and Sites](reference/cost-barriers/executive-summary/e34-increasing-competition-for-qualified-investigators-and-sites.md)
        - [Regulatory and Administrative Barriers in Clinical Research](reference/cost-barriers/executive-summary/e35-regulatory-and-administrative-barriers.md)
        - [Drug Sponsor-Imposed Barriers in Clinical Trials](reference/cost-barriers/executive-summary/e36-drug-sponsor-imposed-barriers.md)
        - [Disconnect Between Clinical Research and Medical Care](reference/cost-barriers/executive-summary/e37-disconnect-between-clinical-research-and-medical-care.md)
        - [Barriers to Clinical Trials at Academic Institutions](reference/cost-barriers/executive-summary/e38-barriers-at-academic-institutions.md)
        - [Barriers in Global Clinical Research](reference/cost-barriers/executive-summary/e39-barriers-related-to-the-globalization-of-clinical-research.md)
        - [Barriers to Clinical Trials and Mitigation Strategies](reference/cost-barriers/executive-summary/e4-analysis-of-barriers-to-clinical-trials.md)
      - [Data Sources for Clinical Trial Decision-Making Model](reference/cost-barriers/21-data-sources.md)
      - [Publically Available Literature on Pharmaceutical Decision-Making](reference/cost-barriers/211-publically-available-literature.md)
      - [Discussions on Drug Development Decision Processes](reference/cost-barriers/212-discussions-with-experts-fda-personnel-drug-sponsors-contract-research-organizations-cros-and-academic-clinical-research-centers.md)
      - [Medidata Solutions Databases for Clinical Trial Costs](reference/cost-barriers/213-medidata-solutions-databases.md)
      - [Conceptual Framework for Clinical Trial Decision-Making](reference/cost-barriers/22-conceptual-framework.md)
      - [Operational Model for Clinical Trial Cost Analysis](reference/cost-barriers/23-operational-model.md)
      - [Model Parameters for Clinical Trial Cost Analysis](reference/cost-barriers/24-model-parameters.md)
      - [Clinical Trial Costs by Therapeutic Area](reference/cost-barriers/31-costs-by-therapeutic-area.md)
      - [Clinical Trial Costs by Phase](reference/cost-barriers/32-costs-by-trial-phase.md)
      - [Clinical Trial Costs by Cost Component](reference/cost-barriers/33-costs-by-cost-component.md)
      - [Key Drivers of Clinical Trial Costs by Therapeutic Area and Phase](reference/cost-barriers/34-conclusions.md)
      - [High Financial Cost of Clinical Research and Drug Development](reference/cost-barriers/41-high-financial-cost.md)
      - [Lengthy Timelines in Clinical Trials and Drug Development](reference/cost-barriers/42-lengthy-timelines.md)
      - [Difficulties in Recruiting and Retaining Clinical Trial Participants](reference/cost-barriers/43-difficulties-in-recruiting-and-retaining-participants.md)
      - [Competition for Qualified Investigators and Sites](reference/cost-barriers/44-increasing-competition-for-qualified-investigators-and-sites.md)
      - [Regulatory and Administrative Barriers in Clinical Research](reference/cost-barriers/45-regulatory-and-administrative-barriers.md)
      - [Regulations Protecting Human Research Subjects and Privacy](reference/cost-barriers/451-regulations-protecting-human-research-subjects-and-their-privacy.md)
      - [Safety Reporting Requirements for INDs and Biologics](reference/cost-barriers/452-safety-reporting-requirements-for-investigational-new-drugs-inds-and-biologics-21-cfr-312.md)
      - [Regulations for Multi-Jurisdiction Clinical Trials](reference/cost-barriers/453-regulations-for-multiple-jurisdictions.md)
      - [FDA's Conservative Regulatory Climate](reference/cost-barriers/454-conservative-regulatory-climate.md)
      - [Lack of Clear Regulatory Pathways for Some Therapeutic Areas](reference/cost-barriers/455-lack-of-clear-regulatory-pathways-and-guidance-for-some-therapeutic-areas.md)
      - [Barriers in the FDA Review Process](reference/cost-barriers/456-barriers-related-to-the-review-process.md)
      - [Drug Sponsor-imposed Barriers in Clinical Research](reference/cost-barriers/46-drug-sponsor-imposed-barriers.md)
      - [Administrative Inefficiencies in Drug Development](reference/cost-barriers/461-administrative.md)
      - [Enrollment Restrictions in Clinical Trials](reference/cost-barriers/462-study-design.md)
      - [Data and Site Monitoring Costs in Clinical Trials](reference/cost-barriers/463-data-and-site-monitoring.md)
      - [Serious Adverse Events Reporting for INDs](reference/cost-barriers/464-serious-adverse-events-saes-reporting-for-investigational-new-drugs-and-biologics-inds-21-cfr-312.md)
      - [Disconnect Between Clinical Research and Medical Care](reference/cost-barriers/47-disconnect-between-clinical-research-and-medical-care.md)
      - [Barriers at Academic Institutions for Clinical Trials](reference/cost-barriers/48-barriers-at-academic-institutions.md)
      - [Globalization Barriers in Clinical Research](reference/cost-barriers/49-barriers-related-to-the-globalization-of-clinical-research.md)
      - [Use of Electronic Health Records in Clinical Trials](reference/cost-barriers/51-use-of-electronic-health-records-ehr.md)
      - [Relaxing Trial Enrollment Restrictions](reference/cost-barriers/52-relaxing-trial-enrollment-restrictions.md)
      - [Simplified Clinical Trial Protocols and Reduced Amendments](reference/cost-barriers/53-simplified-clinical-trial-protocols-and-reduced-amendments.md)
      - [Reduced Source Data Verification in Clinical Trials](reference/cost-barriers/54-reduced-source-data-verification-sdv.md)
      - [Wider Use of EDC in Clinical Trials](reference/cost-barriers/55-wider-use-of-mobile-technologies-such-as-electronic-data-capture-edc.md)
      - [Lower-cost Facilities and At-home Testing in Clinical Trials](reference/cost-barriers/56-wider-use-of-lower-cost-facilities-andor-at-home-testing.md)
      - [Priority Review Vouchers](reference/cost-barriers/57-priority-reviewpriority-review-vouchers.md)
      - [FDA Review Process Efficiency and Advisory Committee Impact](reference/cost-barriers/58-improvements-in-fda-review-process-efficiency-and-more-frequent-and-timely-interactions-with-fda.md)
      - [Barrier Mitigation Strategies in Drug Development](reference/cost-barriers/59-conclusions.md)
    - [FDA References and Data Resources](reference/12-references.md)
    - [Data Storage Costs for Decentralized Clinical Trials](reference/data-storage-costs.md)
    - [Historical Evidence for Decentralized Efficacy Trials](reference/historical-evidence-supporting-decentralized-efficacy-trials.md)
    - [üìò Historical Evidence Supporting Real-World Efficacy Trials](reference/historical-evidence-supporting-real-wold-efficacy-trials.md)
    - [History of Medical Regulation and Clinical Research](reference/history-of-medical-regulation-and-clinical-research.md)
    - [üìà Impact of Innovative Medicines on Life Expectancy](reference/impact-of-innovative-medicines-on-life-expectancy.md)
    - [Efficiency of NIH Research Funding vs. an Automated Decentralized Trial Platform](reference/nih-recover-initiative.md)
    - [Estimated Lives Saved by Increased Drug Accessibility](reference/otc-drugs.md)
    - [Pragmatic vs Explanatory Trials: A Quantitative Analysis](reference/pragmatic-trials.md)
    - [Scaling RECOVERY Trial Efficiency with Decentralized Platforms](reference/recovery-trial.md)
    - [References](reference/references.md)
    - [Pharmaceutical R&D Spending and Outcomes](reference/Research-and-Development-in-the-Pharmaceutical-Industry.md)
    - [Economic Value of Accelerating Medical Progress Through New Therapies](reference/value-of-new-treatment.md)
  - üìÅ **reference-databases/**
    - [biomarker-databases](reference-databases/biomarker-databases.md)
    - [diseases](reference-databases/diseases.md)
    - [food-databases](reference-databases/food-databases.md)
    - [medication-databases](reference-databases/medication-databases.md)
    - [README](reference-databases/README.md)
    - [supplement-databases](reference-databases/supplement-databases.md)
    - [units](reference-databases/units.html)
    - [units](reference-databases/units.md)
  - üìÅ **regulatory/**
    - [cost-benefit-analysis-framework-for-rational-drug-classification](regulatory/cost-benefit-analysis-framework-for-rational-drug-classification.md)
    - [Decentralized FDA Transformation Proposal](regulatory/dfda-executive-order.md)
    - [HHS Policy Recommendations for Disease Eradication](regulatory/hhs-policy-recommendations.md)
  - üìÅ **scripts/**
    - [Scripts Directory for Repository Management](scripts/README.md)
  - üìÅ **strategy/**
    - [dFDA Implementation Plan: Privacy-Preserving Treatment Review Aggregation](strategy/implementation-plan.md)
    - [Patient Industrial Complex Advocacy System](strategy/patient-industrial-complex.md)
    - [Roadmap to a Global Autonomous Decentralized FDA](strategy/roadmap.md)
    - [Strategies for Global Autonomous Decentralized FDA](strategy/strategy-comparison.md)
    - [High-Level Strategy for War on Disease](strategy/war-on-disease-strategy.md)
  - üìÅ **wiki/**
    - üìÅ **interventions/**
      - [Brain Computer Interfaces For Depression](wiki/interventions/brain-computer-interfaces-for-depression.md)
      - [dmt](wiki/interventions/dmt.html)
      - [ISRIB](wiki/interventions/ISRIB.html)
    - üìÅ **open-source/**
      - [open-health-standards](wiki/open-source/open-health-standards.html)
    - [9_Me_BC_(9_Methyl_carboline)](wiki/9_Me_BC_(9_Methyl_carboline).html)
    - [Adaptive_Platform_for_Personalized_Engagement](wiki/Adaptive_Platform_for_Personalized_Engagement.html)
    - [Adderall](wiki/Adderall.html)
    - [Aetna](wiki/Aetna.html)
    - [All_of_Us_Research_Program_Research_Workbench](wiki/All_of_Us_Research_Program_Research_Workbench.html)
    - [All_of_Us_Research_Program](wiki/All_of_Us_Research_Program.html)
    - [Alzheimer_s_Project](wiki/Alzheimer_s_Project.html)
    - [Anhedonia](wiki/Anhedonia.html)
    - [Anthem](wiki/Anthem.html)
    - [Antidepressant_Reviews](wiki/Antidepressant_Reviews.html)
    - [Application_Programming_Interface_API](wiki/Application_Programming_Interface_API.html)
    - [Attention_Deficit_Disorder_ADD](wiki/Attention_Deficit_Disorder_ADD.html)
    - [Automatic_Pill_Dispensers](wiki/Automatic_Pill_Dispensers.html)
    - [Bastian_Greshake_Tzovaras](wiki/Bastian_Greshake_Tzovaras.html)
    - [Benefits_of_Exercise](wiki/Benefits_of_Exercise.html)
    - [Blood_Brain_Barrier](wiki/Blood_Brain_Barrier.html)
    - [Blood_Glucose_Tracking](wiki/Blood_Glucose_Tracking.html)
    - [Blood_Pressure](wiki/Blood_Pressure.html)
    - [BPC_157](wiki/BPC_157.html)
    - [Bromantane](wiki/Bromantane.html)
    - [Centene](wiki/Centene.html)
    - [Cigna](wiki/Cigna.html)
    - [Clinical_Discoveries_from_Real_World_Evidence](wiki/Clinical_Discoveries_from_Real_World_Evidence.html)
    - [Crowdsourced_Research_Projects](wiki/Crowdsourced_Research_Projects.html)
    - [Crowdsourcing_Cures_App](wiki/Crowdsourcing_Cures_App.html)
    - [Crowdsourcing_Cures_Platform](wiki/Crowdsourcing_Cures_Platform.html)
    - [decentralized-autonomous-organization](wiki/decentralized-autonomous-organization.html)
    - [Dementia_Society_of_America](wiki/Dementia_Society_of_America.html)
    - [development](wiki/development.html)
    - [Differentiation_Between_a_Supplement_and_a_Drug](wiki/Differentiation_Between_a_Supplement_and_a_Drug.html)
    - [Dimethyl_sulfoxide_DMSO_](wiki/Dimethyl_sulfoxide_DMSO_.html)
    - [Diseases_Associated_with_Intestinal_Permeability](wiki/Diseases_Associated_with_Intestinal_Permeability.html)
    - [Dopaminergic_Repair_Stack](wiki/Dopaminergic_Repair_Stack.html)
    - [FDA_Mandate_Initiative](wiki/FDA_Mandate_Initiative.html)
    - [federated-learning](wiki/federated-learning.html)
    - [Glyphosate](wiki/Glyphosate.html)
    - [GNU_Health](wiki/GNU_Health.html)
    - [Grant_Opportunities](wiki/Grant_Opportunities.html)
    - [Grant_Proposal_Template](wiki/Grant_Proposal_Template.html)
    - [Habit_Dash](wiki/Habit_Dash.html)
    - [Health_Care_Service_Corporation_HCSC](wiki/Health_Care_Service_Corporation_HCSC.html)
    - [health-scores](wiki/health-scores.html)
    - [Heart_Rate_Variability_HRV](wiki/Heart_Rate_Variability_HRV.html)
    - [homomorphic-encryption](wiki/homomorphic-encryption.html)
    - [Humana](wiki/Humana.html)
    - [IC50](wiki/IC50.html)
    - [intellectual-property](wiki/intellectual-property.html)
    - [International_Biobank_Health_Data_Sharing](wiki/International_Biobank_Health_Data_Sharing.html)
    - [Intraosseous](wiki/Intraosseous.html)
    - [ISRIB_(Integrated_Stress_Response_Inhibitor)](wiki/ISRIB_(Integrated_Stress_Response_Inhibitor).html)
    - [Joe_Cohen](wiki/Joe_Cohen.html)
    - [Joint_Venture_Structures](wiki/Joint_Venture_Structures.html)
    - [Journal_of_Citizen_Science](wiki/Journal_of_Citizen_Science.html)
    - [Kaiser_Permanente](wiki/Kaiser_Permanente.html)
    - [Ketamine](wiki/Ketamine.html)
    - [L_Tyrosine](wiki/L_Tyrosine.html)
    - [Larazotide_Acetate](wiki/Larazotide_Acetate.html)
    - [Leaky_Gut_Tests](wiki/Leaky_Gut_Tests.html)
    - [links](wiki/links.html)
    - [Lipopolysaccharides_LPS](wiki/Lipopolysaccharides_LPS.html)
    - [LongeCity](wiki/LongeCity.html)
    - [Main_Page](wiki/Main_Page.html)
    - [MAO_A](wiki/MAO_A.html)
    - [MAO_B](wiki/MAO_B.html)
    - [Measuring_Cognitive_Performance](wiki/Measuring_Cognitive_Performance.html)
    - [Medical_Ethics](wiki/Medical_Ethics.html)
    - [Microbiome_Optimization_Initiative](wiki/Microbiome_Optimization_Initiative.html)
    - [Million_Friends](wiki/Million_Friends.html)
    - [Monoamine_oxidase_inhibitors_MAOIs](wiki/Monoamine_oxidase_inhibitors_MAOIs.html)
    - [Monoamine_transporter_optimization](wiki/Monoamine_transporter_optimization.html)
    - [Neuroinflammation](wiki/Neuroinflammation.html)
    - [Nonprofit_Fiscal_Sponsors](wiki/Nonprofit_Fiscal_Sponsors.html)
    - [Nutrition_for_Precision_Health](wiki/Nutrition_for_Precision_Health.html)
    - [Omada_Insights_Lab](wiki/Omada_Insights_Lab.html)
    - [Open_Cures](wiki/Open_Cures.html)
    - [Open_Epidemiology_Initiative](wiki/Open_Epidemiology_Initiative.html)
    - [Open_Food_Facts](wiki/Open_Food_Facts.html)
    - [Open_Humans](wiki/Open_Humans.html)
    - [Open_Source_Food_Projects](wiki/Open_Source_Food_Projects.html)
    - [optimization](wiki/optimization.html)
    - [Organic_Small_Molecules_Database_GDB_17](wiki/Organic_Small_Molecules_Database_GDB_17.html)
    - [Parnate](wiki/Parnate.html)
    - [PEA](wiki/PEA.html)
    - [Phenelzine_Nardil_versus_Tranylcypromine_Parnate](wiki/Phenelzine_Nardil_versus_Tranylcypromine_Parnate.html)
    - [Posthumous_Health_Data_Donation_by_Default](wiki/Posthumous_Health_Data_Donation_by_Default.html)
    - [PrecisionFDA](wiki/PrecisionFDA.html)
    - [Predictors_of_Dementia](wiki/Predictors_of_Dementia.html)
    - [Pregnenolone](wiki/Pregnenolone.html)
    - [Public_Money_Public_Code_Initiative](wiki/Public_Money_Public_Code_Initiative.html)
    - [Quantified_Self_Data_Aggregators](wiki/Quantified_Self_Data_Aggregators.html)
    - [quantified-self-aggregators](wiki/quantified-self-aggregators.html)
    - [Relationship_between_depression_and_chronic_periodontitis](wiki/Relationship_between_depression_and_chronic_periodontitis.html)
    - [Relative_Nutritional_Deficiency](wiki/Relative_Nutritional_Deficiency.html)
    - [Relative_Risk_RR_](wiki/Relative_Risk_RR_.html)
    - [Research_Chemicals](wiki/Research_Chemicals.html)
    - [Standardized_Clinical_Trial_Outcome_Measures](wiki/Standardized_Clinical_Trial_Outcome_Measures.html)
    - [Stuff_That_Works](wiki/Stuff_That_Works.html)
    - [Techniques_for_Dealing_With_Negative_Thoughts_and_Emotions](wiki/Techniques_for_Dealing_With_Negative_Thoughts_and_Emotions.html)
    - [Tests_to_Diagnose_Alzheimer_s_Disease](wiki/Tests_to_Diagnose_Alzheimer_s_Disease.html)
    - [Tourniquets](wiki/Tourniquets.html)
    - [Tranylcypromine_Parnate_](wiki/Tranylcypromine_Parnate_.html)
    - [Tyramine_Avoidance_Diet](wiki/Tyramine_Avoidance_Diet.html)
    - [United_Healthcare](wiki/United_Healthcare.html)
    - [Utilitropic](wiki/Utilitropic.html)
    - [venture-capital](wiki/venture-capital.html)
    - [We_the_People_petitioning_system_](wiki/We_the_People_petitioning_system_.html)
    - [Wellbeing_Adjusted_Life_Years](wiki/Wellbeing_Adjusted_Life_Years.html)
    - [WellCare](wiki/WellCare.html)
    - [Zonulin_Tests](wiki/Zonulin_Tests.html)
    - [Zonulin](wiki/Zonulin.html)
  - [Problems We Can Solve with a Decentralized FDA](01-problem.md)
  - [Personalized Precision Medicine Framework](02-solution.md)
  - [üè≠ Platform](03-platform.md)
  - [dFDA Top-Level Pages](dfda-sitemap.md)
  - [Economic Models and Cost-Benefit Analyses of Decentralized FDA](economic-models.md)
  - [üí° The Decentralized FDA](home.md)
  - [A Logical Proof That We Should Immediately Create A Decentralized FDA](logical-proof-to-focus-on-dfda.md)
  - [Decentralized Autonomous FDA (dFDA) Proposal](one-pager.md)
  - [DFDA Wiki Sitemap](SITEMAP.md)
  - [TREE](TREE.md)
